FDA guides on molecular targeted therapies beyond cancer

FDA has released two new draft guidance documents that are intended to help extend some of the scientific and regulatory advances that have been made in targeted therapies for cancer to other diseases. FDA has previously signaled that it will approve cancer drugs

Read the full 437 word article

User Sign In